Walter M, Bentz D, Schicktanz N, Milnik A, Aerni A, Gerhards C, Schwegler K, Vogel M, Blum J, Schmid O, Roozendaal B, Lang U E, Borgwardt S, de Quervain D
Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland.
1] Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland [2] Division of Cognitive Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland.
Transl Psychiatry. 2015 Jul 28;5(7):e610. doi: 10.1038/tp.2015.101.
Heroin dependence is a severe and chronically relapsing substance use disorder with limited treatment options. Stress is known to increase craving and drug-taking behavior, but it is not known whether the stress hormone cortisol mediates these stress effects or whether cortisol may rather reduce craving, for example, by interfering with addiction memory. The aim of the present study was to determine the effects of cortisol administration on craving in heroin-dependent patients and to determine whether the effects depend on the daily dose of heroin consumption. We used a double-blind, placebo-controlled, cross-over study in 29 heroin-dependent patients in a stable heroin-assisted treatment setting. A single oral dose of 20 mg of cortisol or placebo was administered 105 min before the daily heroin administration. The primary outcome measure was cortisol-induced change in craving. Secondary measures included anxiety, anger and withdrawal symptoms. For the visual analog scale for craving, we found a significant interaction (P = 0.0027) between study medication and heroin-dose group (that is, daily low, medium or high dose of heroin). Cortisol administration reduced craving in patients receiving a low dose of heroin (before heroin administration: P = 0.0019; after heroin administration: P = 0.0074), but not in patients receiving a medium or high dose of heroin. In a picture-rating task with drug-related pictures, cortisol administration did not affect the ratings for the picture-characteristic craving in all the three heroin-dose groups. Cortisol also did not significantly affect secondary outcome measures. In conclusion, a single administration of cortisol leads to reduced craving in low-dose heroin addicts. The present findings might have important clinical implications with regard to understanding stress effects and regarding treatment of addiction.
海洛因依赖是一种严重的慢性复发性物质使用障碍,治疗选择有限。已知压力会增加渴望和吸毒行为,但尚不清楚应激激素皮质醇是否介导这些压力效应,或者皮质醇是否可能通过干扰成瘾记忆等方式反而减轻渴望。本研究的目的是确定给予皮质醇对海洛因依赖患者渴望的影响,并确定这些影响是否取决于每日海洛因消费量。我们在29名处于稳定的海洛因辅助治疗环境中的海洛因依赖患者中进行了一项双盲、安慰剂对照的交叉研究。在每日服用海洛因前105分钟口服单剂量20毫克皮质醇或安慰剂。主要结局指标是皮质醇引起的渴望变化。次要指标包括焦虑、愤怒和戒断症状。对于渴望的视觉模拟量表,我们发现研究药物与海洛因剂量组(即每日低、中或高剂量海洛因)之间存在显著交互作用(P = 0.0027)。给予皮质醇可减轻低剂量海洛因患者的渴望(服用海洛因前:P = 0.0019;服用海洛因后:P = 0.0074),但对中剂量或高剂量海洛因患者无效。在一项与毒品相关图片的图片评分任务中,给予皮质醇对所有三个海洛因剂量组的图片特征渴望评分均无影响。皮质醇也未显著影响次要结局指标。总之,单次给予皮质醇可减轻低剂量海洛因成瘾者的渴望。本研究结果可能对理解压力效应和成瘾治疗具有重要的临床意义。